STUDresearch · Peptide

Glutathione

Also known as

GSH · L-glutathione · reduced glutathione · liposomal glutathione · S-acetyl glutathione (SAG) · γ-L-glutamyl-L-cysteinylglycine · Setria glutathione (branded oral form discussions) · oxidized glutathione (GSSG)

Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.

Open in the directory ↗

Peptide Some talk Systemic Oral / IV Antioxidant & detox discussion

Mostly systemic—oral, liposomal and IV use dominate antioxidant, liver and skin talk; topical, airway and intranasal contexts remain route-specific.

What people say Glutathione is an endogenous glutamate-cysteine-glycine antioxidant. Oral reduced, liposomal, S-acetyl and IV forms have different exposure evidence and cannot share one route claim. Doses people talk about

Inspected oral self-reports150 mg liposomal or 250 mg oral glutathione

Reports ranged from no effect after weeks to months to perceived recovery/sleep changes or dizziness and stopping. Product form and co-supplements varied.

Six-month oral RCT250 mg/day or 1,000 mg/day reduced glutathione

Parallel randomized human study of repeated oral exposure and body glutathione stores; not an acute felt-effect trial.

Four-week liposomal pilot500 mg/day or 1,000 mg/day liposomal glutathione

Small 12-person uncontrolled pilot measuring blood and cellular glutathione-related outcomes; not equivalent to standard capsules.

Single-dose oral bioavailability study3 g reduced glutathione once

Seven-person study found no significant acute plasma increase; this does not negate longer repeated-exposure studies or other formulations.

Community amounts lead where available, followed by human-study contexts. Rows describe reports and study arms, not a progression or personal protocol.

Half-life & effect duration

Half-life in the body: IV · reduced glutathioneAbout 7 minutes
IV · total glutathioneAbout 14 minutes
Separate IV studyAbout 10 minutes
Felt duration people report: Positive oral accountsBetter recovery or sleep
IV community reportsBrief warmth or flushing; clearer feeling sometimes fading within hours
Other accountsNo change after weeks to months, or calming, tiredness and dizziness

Timing context & sources

How it may feel Many oral users notice little acutely. Inspected reports include perceived recovery or sleep benefit, no effect after weeks to months, and calming/tired or dizzy responses that led one user to stop; formulation and co-supplements varied.

Cycles people discuss Oral trials and self-reports use continuous multi-week or multi-month exposure, while IV aesthetic culture uses session blocks. These are route- and goal-specific study or practice windows, not one cycle. Timing Oral timing habits vary between empty stomach, meals and evening use; no single pattern is established in these notes. IV clinic talk instead uses scheduled sessions, often 1–3 times weekly, separate from daily oral routines. Stacks NAC, GlyNAC, glycine and ALA/vitamin C combinations appear in redox and skin discussions. Combining them makes felt-effect attribution and dose equivalence less clear. Watch for IV infusion reactions: Rash, abdominal pain, chest tightness, anaphylaxis/anaphylactoid events reported in aesthetic IV series and case reports; compounding quality and rate of push matter.

Tap a line to jump into the full notes. Research only — may be wrong.

Timing context & sources

Half-life in the body

Small human infusion studies measured minutes-scale plasma disappearance after IV glutathione.

An FDA evidence review summarizes reduced-GSH half-life at 7.0 ± 3.5 minutes and total glutathione at 14.1 ± 9.2 minutes after 2 g/m² IV exposure; another seven-man study reported approximately 10 minutes after 50 mg/kg infusion.

Small healthy-volunteer IV studies; reduced versus total analytes differ. These figures do not transfer to oral, liposomal, S-acetyl, topical, airway or intracellular glutathione pools.

FDA Pharmacy Compounding Advisory Committee review — glutathione (opens in a new tab)Pharmacokinetics section summarizing small healthy-volunteer IV studies, including reduced glutathione half-life 7.0 ± 3.5 minutes and total glutathione half-life 14.1 ± 9.2 minutes after 2 g/m² IV administration.Regulatory evidence review rather than a new experiment. Values reflect specific IV doses, analytes and small healthy cohorts; they are not oral or intracellular half-lives.
Pharmacokinetics of glutathione and its metabolites in normal subjects (opens in a new tab)Abstract and methods/results: seven healthy young men received 50 mg/kg glutathione by 10-minute IV infusion; plasma glutathione disappearance half-life was approximately 10 minutes.Seven healthy men and a high IV dose; older study methods and no transfer to oral formulations, tissue stores or subjective duration.

Felt duration people report

The inspected oral reports conflict and do not establish a dependable felt window.

Reports included perceived recovery/sleep benefit, no change after weeks to months, and calming/tired or dizzy effects followed by stopping. One severe mixed-supplement thread was treated as confounded rather than glutathione-specific proof.

Self-selected products, different formulations and amounts, co-supplements, no assays or blinded rechallenge, and sparse same-author follow-up.

How long did it take to feel glutathione benefits? (opens in a new tab)Complete post and visible replies: S-acetyl recovery/sleep benefit claim; a 150 mg liposomal user reporting no effect after weeks to months; another liposomal user describing calming/tired and dizzy effects and later reporting discontinuation because of dizziness.Mixed products, amounts and goals; uncontrolled and self-selected reports with no product assay, biomarker confirmation or blinded comparison.
Glutathione messed me up — mixed adverse-report thread (opens in a new tab)Original post, same-author follow-ups and visible replies: anxiety in a mixed-supplement setting; a separate 250 mg account; and a liposomal user describing palpitations/dehydration and emergency evaluation.Severe reports are medically important but highly confounded by co-supplements, formulation, hydration, underlying conditions and self-attribution; no causal adjudication.
Randomized controlled trial of oral glutathione supplementation on body stores (opens in a new tab)PubMed abstract: 54 adults randomized to placebo, 250 mg/day or 1,000 mg/day oral glutathione for six months, with repeated blood and tissue-related glutathione measures.Repeated-exposure biomarker trial, not acute oral pharmacokinetics or a controlled test of subjective onset; product-specific findings do not cover every formulation.

Other context in this card

Oral liposomal glutathione supplementation pilot (opens in a new tab)PubMed abstract: 12 adults received 500 or 1,000 mg/day liposomal glutathione for four weeks with whole-blood, red-cell, plasma and PBMC glutathione-related measurements.Small uncontrolled pilot, short follow-up, biomarker endpoints and formulation-specific exposure; it does not establish a population felt window.
Systemic availability of oral glutathione (opens in a new tab)PubMed abstract: seven healthy volunteers received a single 3 g oral dose, with no significant plasma glutathione increase detected over the studied window.Very small single-dose study of one oral preparation; it does not negate repeated-use, enhanced-delivery or tissue-compartment findings.

What people say 15

Recovery / “detox” anecdotes: IV or high-dose oral for soreness, hangover, or post-indulgence “clear” feel — heavily confounded by saline, vitamins, rest, and placebo. anecdote
Precursor alternative wins debates: Many longevity threads prefer GlyNAC or NAC alone over direct oral GSH because cells regulate synthesis and chronic oral absorption debates never fully died. forum
Stack confounds: Benefits often credited inside NAC + glycine + ALA + vitamin C + selenium nests — hard to isolate GSH alone. forum
Chronic oral body stores (Setria-style): 6-month RCT of oral GSH 250 or 1,000 mg/day raised blood/compartment GSH in a dose- and time-dependent way; high dose ~30–35% in erythrocytes, plasma, and lymphocytes at 6 months; levels fell back after ~1-month washout. trial
Liposomal oral stores: 1-month pilot of liposomal GSH 500 or 1,000 mg/day reported whole-blood GSH up within ~1 week, peaking ~2 weeks (e.g. ~40% whole blood, large PBMC rise); oxidative markers fell; NK cytotoxicity rose sharply in that small sample. trial
Micellar / enhanced oral PK: Newer pilot work compared micellar (e.g. LipoMicel 300 mg) vs standard reduced GSH 500 mg and liposomal Setria 300 mg — higher incremental plasma GSH exposure claimed for micellar at the studied doses; 30-day ~600 mg/day micellar safety markers looked quiet in healthy adults. trial
Immune markers: Short liposomal and higher-dose oral windows report higher NK-cell cytotoxicity; clinical infection outcomes are not established from that alone. trial
Skin / melasma oral RCTs: Systematic reviews cite oral GSH ~250 mg once daily, 250 mg BID, or 500 mg once daily over multi-week blocks with lower melanin index or MASI vs placebo; effect size modest and often reverses after stop. trial
Oral + co-factors skin stack: One multicenter RCT used 500 mg L-GSH + 250 mg ascorbic acid + 50 mg ALA + zinc aspartate daily × 12 weeks — lightening signal mixed/not uniformly significant; hard to credit GSH alone. trial
Topical pigmentation: Topical reduced GSH ~0.1–0.5% (0.5% often better than 0.1%) and 2% oxidized GSSG lotion or 2% cream discussed for localized brightening; oral + topical combo sometimes ranked above monotherapy. trial
IV aesthetic clinics: Med-spas market IV GSH for “glow”/whitening; one small placebo-controlled IV series (e.g. 1,200 mg twice weekly × 6 weeks) reported temporary lightening in a minority (about 37.5% vs ~18.7% placebo, p near 0.05) with high adverse-event rates — durable whitening evidence remains weak. trial
NAFLD / liver pilots: Open-label oral GSH ~300 mg/day for ~3–4 months in NAFLD cohorts discussed with ALT and some fat/oxidative marker improvements — pilot-level, not definitive NASH treatment. trial
Parkinson’s IV history: Open-label early PD series used IV GSH 600 mg twice daily × 30 days with temporary motor gains lasting weeks–months after stop; later double-blind pilot (1,400 mg IV 3×/week × 4 weeks) was well tolerated with only mild, non-significant UPDRS trends. trial
Intranasal PD research: Phase IIb-style programs studied ~300 or 600 mg/day intranasal GSH as a less invasive brain-delivery idea; still research, not consumer standard. trial
PAD walking distance: Short hospital-style IV GSH twice daily × 5 days improved pain-free walking distance and leg-flow measures vs saline in one RCT — not the main wellness use case. trial

Doses people talk about 20

Oral reduced capsules (retail general use): ~250–500 mg once daily is the most common “everyday antioxidant/skin” band. forum
Consumer whitening product labels: Marketed pills sometimes list ~500–2,000 mg/day (occasionally higher combo “stacks”) — label claims ≠ verified exposure or trial replication. forum
S-acetyl glutathione (SAG): Marketed as more stable/absorbable acetylated form; human comparative dose culture is less standardized than plain/liposomal mg charts — treat mg as non-interchangeable across forms. forum
IV aesthetic / wellness clinic (common talk): ~600–1,200 mg per session, often 1–3×/week for several weeks; some menus advertise 1,500–4,000 mg/session for “intensive brightening” without standardized protocols. forum
IM injection: Discussed less than IV in modern wellness menus; still appears in some clinic “shot” packages, often with vitamin C. forum
Sublingual / buccal sprays & lozenges: Marketed as absorption workarounds; labeled mg rarely equal verified systemic exposure. forum
Uncertainty rule: Formulation (plain vs liposomal vs micellar vs S-acetyl), brand purity, and whether co-ingredients are present matter as much as the number on the label. forum
Oral liposomal trial/product band: ~250–1,000 mg/day; pilot work specifically used 500 and 1,000 mg/day for 1 month. trial
Oral micellar / enhanced PK pilots: Single-dose comparisons around ~300 mg micellar vs ~300 mg liposomal vs ~500 mg standard; multi-day safety arms around ~600 mg/day discussed. trial
IV skin trial example: ~1,200 mg IV twice weekly for 6 weeks in a small whitening study (temporary effect, substantial adverse events reported). trial
IV PAD research example: IV GSH twice daily for 5 consecutive days (exact mg per infusion less consistently quoted in secondary summaries than the schedule). trial
Intranasal PD research: ~300 or 600 mg/day total (often split) in clinical-program discussions. trial
Nebulized / inhaled (minority, research/clinic): Example challenge/use figures include ~600 mg nebulized in saline; CF and other airway programs have used multi-hundred-mg multi-month schedules — not a casual home protocol. trial
Topical dermatology: Reduced GSH creams/lotions often ~0.1–0.5% (sometimes up to ~2% reduced or oxidized GSSG 2% lotion); typically 1–2× daily to face for weeks. trial
Framing: Ranges below are discussed in communities, product labels, and studies — not advice, prescriptions, or personal protocols. forum
Oral chronic body-store RCT band: 250 mg/day (low) or 1,000 mg/day (high) for 6 months (Setria reduced GSH) is the landmark long oral reference. trial
Skin oral RCT band: ~250 mg once daily, 250 mg twice daily (500 mg total), or 500 mg once daily over multi-week to ~12-week windows. trial
NAFLD oral pilot: ~300 mg/day oral reduced GSH for ~3–4 months in small open-label cohorts. trial
IV Parkinson’s research examples: Open-label 600 mg IV twice daily × 30 days; later pilot 1,400 mg IV three times weekly × 4 weeks. trial
CF oral research note: One discussed pediatric/CF oral reduced GSH figure is ~65 mg/kg/day split TID with meals — disease-context dosing, not general wellness. trial

How it may feel 8

Days 1–7 (oral/liposomal): Little subjective change for most; mild GI (gas, loose stool, nausea) is the common early note. forum
Days 1–3 (IV push/infusion): Short-lived warmth, metallic/sulfur taste, flushing, or same-day “clearer” feel — often fades in hours given short plasma half-life. anecdote
Weeks 6–8 (IV aesthetic blocks): Clinic marketing and small IV whitening series often claim visible tone change after multi-week biweekly sessions; durability still debated. forum
Week 1–2 (liposomal biomarkers): Liposomal pilot peaks in blood/PBMC GSH often around ~2 weeks; energy/skin reassess starts here, not day 2. trial
Weeks 4–12 (skin oral/topical): Melasma/lightening RCTs and clinic talk track color/MASI over ~4–12 weeks, not overnight. trial
Months 1–6 (chronic oral): Richie-style oral work supports time-dependent store building through 6 months at 250–1,000 mg/day; subjective “feel” still often flat. trial
After stopping oral: Blood GSH often returns toward baseline within about a 1-month washout in chronic oral trials — treated as maintenance, not a one-and-done load. trial
After stopping skin/IV goals: Pigment lightening and open-label PD motor gains often fade weeks–months off; maintenance talk is common. trial

Cycles people discuss 8

Continuous oral / liposomal: Many run daily oral with no formal off-cycle for general antioxidant goals; chronic oral trials support ongoing use if the goal is elevated stores. forum
IV aesthetic short courses: Multi-week blocks (e.g. 6–8+ weeks of 1–3 sessions/week, sometimes framed as 10–15 sessions over 2–3 months) more common than lifelong weekly IVs; then monthly maintenance chatter. forum
Precursor rotate: Cost, GI tolerance, or absorption skepticism leads some to rotate GSH ↔ NAC ↔ glycine/GlyNAC rather than stack all forever. forum
Event-based pulses: Wedding/photoshoot/detox-month IV or oral pulses — durability after stop is mixed and often disappointing relative to marketing. forum
Fair oral trial window: ~4–12 weeks before judging skin or subjective energy; biomarker work can show shifts earlier (~1–2 weeks liposomal). trial
Skin-goal blocks: ~8–12 weeks oral and/or topical before maintenance or stop-and-reassess; reverse fade after discontinuation is expected talk. trial
IV research blocks: PD pilots ~4 weeks; PAD protocol 5 consecutive days — fixed research schedules, not wellness templates. trial
Washout evidence: After 6 months oral GSH, levels returned toward baseline in ~1 month off — arguments for maintenance if the goal is sustained elevation. trial

Timing 8

Tissue vs blood: Brief plasma peaks ≠ intracellular GSH pools (liver hours-scale turnover talk; RBC/spleen/nerve pools longer). That gap fuels “why take it if half-life is minutes?” debates. forum
Why multi-session IV schedules exist: Short circulating window is used to justify multi-times-weekly clinic drips rather than a depot model. forum
Oral timing habits: Empty stomach, with meals, or evening — no controlled consensus; liposomal labels often say follow product instructions. forum
With vitamin C (IV talk): Clinics routinely co-infuse or sequential-push vitamin C with GSH; some practitioners claim order/compatibility matters (marketing lore, not a single universal PK standard). forum
Downstream claims: Antioxidant/detox or skin effects are said to outlast free plasma GSH — story and intracellular pools more than continuous blood levels. anecdote
IV / plasma half-life: Free GSH in plasma is very short — often cited ~1–3 minutes physiologically and ~10–15 minutes (commonly ~14 minutes) after IV infusion in clinical PK talk; plasma spikes are brief. trial
Why chronic daily oral can still work: Richie-style multi-month oral work argues gradual compartment repletion despite bad single-dose plasma PK; Witschi 1992 single ~3 g oral dose showed negligible acute plasma rise. trial
Intranasal lag: Research descriptions note brain GSH MRS signals rising over tens of minutes after nasal dose in PD work — different delivery kinetics than IV bolus. trial

Stacks 9

NAC + GSH: Top dual — cysteine precursor plus direct GSH for people who want both synthesis support and exogenous GSH. forum
Glycine alone with GSH: Co-support endogenous synthesis; glycine also appears in sleep stacks so confounds are common. forum
Selenium: Cofactor talk for glutathione peroxidase; small selenium amounts appear in multi-antioxidant nests. forum
Milk thistle (silymarin) / liver nest: GSH or NAC + silymarin for “detox/liver” boards; sometimes TUDCA. forum
IV Myers’-style / brightening drip: Clinic mixes GSH with high-dose vitamin C, B-complex, B12, minerals; spa menus list GSH 1,000–3,000+ mg with multi-gram vitamin C in the same visit. forum
Vitamin C order lore (IV): Many aesthetic protocols insist vitamin C is given with or around GSH for skin goals; ratios are clinic-specific, not a single evidence-based fixed ratio. forum
NAD+ / mito adjacency: Longevity IV menus sometimes pair GSH drips with NAD+ on separate or same-day visits — pure marketing adjacency. forum
GlyNAC instead of / alongside GSH: Glycine + NAC (often ~1:1, e.g. multi-gram totals split BID in aging trials; weight-based ~100 mg/kg each in some older-adult work) framed as letting cells make regulated GSH — longevity forums often prefer this over mega-dose oral GSH. trial
ALA + vitamin C + GSH: Classic redox-recycle trio; oral skin combo products and Indonesian RCT co-ingredients used ascorbic acid + ALA + zinc with 500 mg GSH. trial

Storage notes 2

No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum

Related 8

Watch for 13

Taste / sulfur notes: Liposomal liquids and some capsules have sulfur/metallic taste; sublingual forms can be unpleasant. forum
Flushing / headache / systemic: Mild flush, headache, lightheadedness, or brief discomfort — more often reported around IV pushes/infusions. forum
Zinc / mineral lore: Some long-term high-dose oral talk flags mineral balance (zinc appears in combo skin products); evidence that GSH alone depletes minerals is mixed/weak — still a forum talking point. forum
Source / gray-market risk: Unregulated injectables, counterfeit whitening clinics, and research-chem powders add infection, mislabeling, and overdose risk beyond the molecule itself. forum
Form confusion risk: 500 mg plain ≠ 500 mg liposomal ≠ 500 mg S-acetyl in real exposure; copying clinic IV mg into oral plans is a common category error. forum
Not risk-free because “natural”: Endogenous molecule ≠ high-dose exogenous IV/oral is automatically safe; quality, route, and dose dominate risk. forum
GI (oral): Gas, bloating, loose stools, cramping, nausea — most common oral downside in trials and user logs; more likely when pushing multi-hundred-mg–gram totals or empty stomach. trial
IV infusion reactions: Rash, abdominal pain, chest tightness, anaphylaxis/anaphylactoid events reported in aesthetic IV series and case reports; compounding quality and rate of push matter. trial
Hepatic injury (rare but serious): Reversible severe liver injury linked to IV GSH in case report context (example discussed: ~1,200 mg daily with large cumulative monthly dose); Philippine FDA and dermatology reviews have warned against IV GSH for whitening over liver, thyroid, and allergy risks. trial
IV whitening adverse-event rates: Small controlled whitening work reported high AE rates (including liver dysfunction and anaphylaxis signals) — not a “safe aesthetic vitamin.” trial
Inhaled / asthma: Nebulized GSH (~600 mg challenge) induced bronchoconstriction, cough, and breathlessness in mild asthma, linked to sulfite formation in solution — not casual self-experiment territory for asthmatics. trial
Skin lightening sustainability: Oral/topical benefits often reverse after stop; IV whitening lacks strong durable efficacy and draws regulatory/quality critiques. trial
Pregnancy / lactation: Safety data for supplemental/high-dose routes are lacking in standard monographs — research-only posture. trial

Updated: 2026-08-12

Evidence mix More trial/lab tags than forum tags Full: every bullet (trial + community). Use Scan for a faster bro-science read.

↑ Back to top

Half-life & effect duration

Timing context & sources⌄

Half-life in the body

Felt duration people report

Other context in this card

What people say 15

Doses people talk about 20

How it may feel 8

Cycles people discuss 8

Timing 8

More on what it is 7

Stacks 9

Storage notes 2

Related 8

Watch for 13

Timing context & sources